Diagnosis
Candidiasis
A fungal infection caused by yeasts from the genus Candida.
Also known as: Candidosis, Moniliasis, Thrush
Etiology
Cause (>200 species exist) [s9k]
Candida albicans (50-60%)
Candida glabrata (15-20%) --> 15-25% are fluconazole-resistant
Candida parapsilosis (10-20%)
Candida tropicalis (6-12%)
Candida krusei (1-3%)
Candida kefyr (< 5%)
Candida guilliermondi (< 5%)
Candida lusitaniae (< 5%)
Candida dubliniensis (HIV)
Non-candida species: Aspergillus and Cryptococcus species
Pathophysiology [qaz][s9k]
Yeast fungi is a part of the normal flora in the GI tract and vagina (13% of the women)
Fungi causes disease in the immunocompromised and critical ill hospitalized patients
Invasive candidiasis is a leading cause of mycosis-associated mortality
Virulence factors:
Surface adherence molecules
Acid proteases and phospholipases that involve penetration and damage
Ability to convert to a hyphal form
Risk factors
Intensive Care Unit (36% of candidaemia)
Antibiotics (anti-anaerobic agents) [og4]
Corticosteroids
Chemotherapeutics
Immunocompromised host (HIV, transplantation, Diabetes mellitus)
Trauma/burns
Cancer
Catheters
Surgery (abdominal surgery with bowel resection or anastomotic leak)
Renal failure
Mechanical ventilation
Total parenteral nutrition [og4]
Clinical presentations - oral cavity, vagina, penis, GI, respiratory, systemic
Mucocutaneous: intertrigo, diaper dermatitis, erosio interdigitalis blastomycetica, perianal dermatitis, candidal balanitis, paronychia
Oropharyngeal: oral thrush
Esophageal: esophagitis
Nonesophageal gastrointestinal
Genitourinary tract: urinary tract infection, vulvovaginitis, balanitis
Respiratory tract: laryngitis, tracheobronchitis, pneumonia
Systemic: candidemia, endocarditis, myocarditis, pericarditis, endophthalmitis, renal candidiasis, CNS infections, arthritis
Epidemiology
Incidence per 100.000 [qaz][woq][fvp]
Symptoms & findings
Symptoms
Balanitis, Cheilitis, Chills, Cough, Dyspareunia, Dysphagia, Dyspnea, Dysuria, Fever, Hematuria, Nausea, Odynophagia, Onychodystrophy, Onycholysis, Paronychia, Pruritus, Respiratory distress, Urinary urgency, Vaginal discharge, Vomiting, Vulvovaginitis
Clinical findings
Anamneses
Antibiotics, Diabetes mellitus, HIV, Steroids
Localized findings
Approach
Microscopy with KOH
Biopsy
Culture (respiratory, sputum, blood, urin)
Endoscopy
Bronchoscopy
CT abdomen
Echocardiography
Treatment
Guidelines by the Infectious Disease Society of America: [foc]
Candidemia and invasive candiasis
--> Echinocandins (Caspofungin, Micafungin, Anidulafungin)
--> transition to fluconazole/amphotericin B if clinically stable
Localized cutaneous candidiasis --> clotrimazole, econazole, ciclopirox, miconazole, ketoconazole, nystatin
Extensive cutaneous infection or immunocompromised patients --> systemic antifungal therapy
Candida onychomycosis --> oral itraconazole
Paronychia --> fluconazole or itraconazole
Oropharyngeal candidiasis --> topical antifungal agents (nystatin, clotrimazole, amphotericin B oral suspension) or systemic oral azoles (fluconazole, itraconazole, or posaconazole)
Candida esophagitis --> systemic therapy with fluconazole
Vulvovaginal candidiasis --> topical antifungal agents or oral fluconazole
Candida cystitis --> fluconazole
Renal candidiasis --> systemic fluconazole
Chronic mucocutaneous candidiasis --> oral fluconazole
Hepatosplenic candidiasis -->Induction with amphotericin B followed by fluconazole
Respiratory tract candidiasis --> treated as disseminated candidiasis
Surgery:
Abscess formation --> surgical drainage + antifungal therapy
Prosthetic infection --> removal of the prosthesis
Endocarditis --> Valve replacement surgery
Fungal endophthalmitis --> vitrectomy
Differential diagnoses
Abdominal abscess, Aspergillosis, Cryptococcosis, Eczema, Folliculitis, Impetigo, Intertrigo, Onychomycosis, Palmo+C790antar pustolosis, Psoriasis, Sepsis, Tinea
References
[1] R AN, Rafiq NB. Candidiasis. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560624/
[2] Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007 Jan;20(1):133-63.
[3] Nagao et al. Predictors of Candida spp. as causative agents of catheter-related bloodstream infections. Diagnostic Microbiology and Infectious Disease. 2014;80:200-203.
[4] Quindós G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol. 2014 Jan-Mar;31(1):42-8.
[5] Bassetti et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care 23, 219 (2019).
[6] http://emedicine.medscape.com/article/213853; [Medscape]
[7] http://emedicine.medscape.com/article/1090632; [Medscape]
[8] Xiao et al. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China. Antimicrob Resist Infect Control 8, 89 (2019).
[9] Alberto Cortés J, Fernanda Corrales I. Invasive Candidiasis: Epidemiology and Risk Factors. Fungal Infection. IntechOpen; 2019. Available from: http://dx.doi.org/10.5772/intechopen.81813
[10] Yapar, N. (2014). Epidemiology and risk factors for invasive candidiasis. Therapeutics and Clinical Risk Management, 10, 95–105.
[11] Pappas, P., Lionakis, M., Arendrup, M. et al. Invasive candidiasis. Nat Rev Dis Primers 4, 18026 (2018).